Richard Scalzo served as the Senior Vice President, Head of Finance and Administration at Dyne Therapeutics Inc., a biotechnology company focused on developing innovative treatments for genetically driven diseases. In his role, Scalzo was responsible for overseeing the company's financial strategy, administration, and operations, ensuring that Dyne maintained a strong financial position as it worked to advance its pipeline of therapeutic candidates. His leadership was instrumental in guiding the company through various stages of growth and development, including securing funding and managing resources effectively to support the company's research and clinical programs. Prior to joining Dyne Therapeutics, Scalzo had an extensive career in finance and administration within the biotechnology and pharmaceutical industries. He held senior leadership positions at several prominent companies, where he developed a reputation for his strategic financial planning and operational expertise. Scalzo's ability to navigate complex financial landscapes and his deep understanding of the biotech sector made him a valuable asset to Dyne Therapeutics. His contributions helped the company to build a solid foundation for future success, positioning it well within the competitive landscape of genetic medicine development.